We also recently reported that the phosphatases PTPN1 and PTPN2 contribute to crizotinib-resistance in ALK+ ALCL by regulating NPM-ALK and SHP2 phosphorylation (30). The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.